The National Institutes of Health unveiled two new grant programs this week for small research companies that will be supported by stimulus funds provided to the NIH under the American Recovery & Reinvestment Act of 2009. “These new programs will help provide much-needed resources to biotech companies, who are at the cusp of many medical [...]
Filed under: BIO, Uncategorized | Tagged: BIO, financing, NIH, Small Business | Leave a Comment »
The Senate Small Business Committee has passed an SBIR reauthorization bill. We hope the House and Senate will work together to pass a final reauthorization bill before this program is set to expire on September 30, 2008.
From the Puget Sound Business Journal:
Under a compromise negotiated in the U.S. Senate, small companies that are majority-owned [...]
Filed under: BIO, Congress, In the News, SBIR, venture capital | Tagged: BIO, Biotechnology industry, Jim Greenwood, NIH, SBA, SBIR, Senate Small Business Committee, VC, vc-owned firms | 1 Comment »
The feature story in the July 2008 Oncology Business Review is “On-Conversation with Michael Weingarten, Director, Small Business Innovation Research program (SBIR), Office of the Director, National Cancer Institute.”
NOTE: We have highlighted a few of Weingarten’s answers below. Please follow the links for the full interview.
OBR: HOW HAS THIS PROGRAM BEEN ADMINISTERED TO THIS [...]
Filed under: Finding Cures, SBIR, venture capital | Tagged: Cancer, Michael Weingarten, NIH, Phase I, SBIR, venture capital | Leave a Comment »
Families USA released its June 2008 study of NIH grants awarded by state. They conclude that
If the sum of all NIH awards to the states were to increase by 6.6 percent, the national economic benefit would add up to $3.1 billion worth of new business activity, 9,185 additional jobs, and $1.1 billion in new wages
We [...]
Filed under: In the News, Non Profit | Tagged: Families USA, NIH, Science | Leave a Comment »
SBIR Stories
Free Money Myths from the Government
Give Me Fish nets Phase 0 award
Blog Posts
Venture Capital Alternatives: SBIR
Just How Short-sighted is the VC Community?
NIH SBIR Comes to Atlanta
Filed under: In the News, SBIR, venture capital | Tagged: Atlanta, NIH, SBIR, VC | Leave a Comment »
Kickstarting Startups with SBIRs
Editor’s Letter: Capital Offense
Stemina Biomarker receives $150,000 SBIR grant
Boulder-based OptTek focuses on workforce
Lt. Governor Fisher announces $2.7 million in Third Frontier grants Eight companies awarded research commercialization funds
The NIH Conference Comes to Atlanta
DOE awards SBIR grant to Athena Biotechnologies for R&D into 10% drop in ethanol processing by developing heat-tolerant bacteria
Filed under: In the News, SBIR | Tagged: Athena, Lt. Governor Fisher, NIH, OptTek, SBIR, Stemina | Leave a Comment »
Washington Business Journal
The House passed legislation that would make small businesses majority-owned by venture capital firms eligible for Small Business Innovation Research awards.
Through the SBIR program, 2.5 percent of the outside research budgets of 11 federal agencies — including the Department of Defense and the National Institutes of Health — is allocated for small [...]
Filed under: Congress, In the News, SBIR, Uncategorized | Tagged: Congress, NIH, SBIR, small business innovation, Washington Business Journal | Leave a Comment »
Putting the “I” back — that is the “I” in innovation. While we consider SBIR program to be critical to the commercialization of biotechnology for our industry, it is clear that others do not share this view ordiffer on the ways in which this problem should be fixed. For example, Kristie Prinz wrote [...]
Filed under: Finding Cures | Tagged: biotechnology, Congress, Innovation, National Research Council, NIH, SBIR | Leave a Comment »
